Harmony Biosciences, Blackstone Enter Strategic Financing Collaboration For Up To $330M
Harmony Biosciences Holdings, Inc. ("Harmony") (NASDAQ:HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, and